Common use of REPRESENTATIONS AND WARRANTIES 5 Clause in Contracts

REPRESENTATIONS AND WARRANTIES 5. 1. Corporate Existence; Conduct of Business 5.2. Authorization and Validity 5.3. Compliance with Laws and Contracts 5.4. Governmental Consents 5.5. Financial Statements 5.6. Material Adverse Change 5.7. Taxes 5.8. Litigation and Contingent Obligations 5.9. Subsidiaries 5.10. ERISA 5.11. Defaults 5.12. Federal Reserve Regulations 5.13. Investment Company Act 5.14. Certain Fees 5.15. Ownership of Properties 5.16. Collateral 5.17. Material Agreements 5.18. Insurance 5.19. Disclosure ARTICLE VI COVENANTS 6.1. Financial Reporting 6.2. Use of Proceeds 6.3. Notice of Default 6.4. Conduct of Business 6.5. Taxes 6.6. Insurance 6.7. Compliance with Laws 6.8. Maintenance of Properties 6.9. Inspection 6.10. Security Agreement 6.11. Merger 6.12. Sale of Assets 6.13. Investments and Purchases 6.14. Contingent Obligations 6.15. Liens 6.16. Affiliates 6.17. Change in Corporate Structure; Fiscal Year 6.18. Inconsistent Agreements 6.19. Financial Covenants 6.19.1 Minimum Tangible Net Worth 6.19.2. Net Capital Ratio 6.20. ERISA Compliance 6.21. Further Assurances ARTICLE VII DEFAULTS 7.1. Representation or Warranty 7.2. Non-Payment 7.3. Specific Defaults 7.4. Other Defaults 7.5. Cross-Default 7.6. Insolvency; Voluntary Proceedings 7.7. Involuntary Proceedings 7.8. Condemnation 7.9. Judgments 7.10. Security Agreement 7.11. SIPC 7.12. Conduct of Business 7.13. ERISA 7.14. Change in Control 7.15. Official Lien ARTICLE VIII ACCELERATION, WAIVERS, AMENDMENTS AND REMEDIES 8.1. Acceleration 8.2. Amendments 8.3. Preservation of Rights 8.4. Remedies ARTICLE IX GENERAL PROVISIONS 9.1. Survival of Representations 9.2. Governmental Regulation 9.3. Headings 9.4. Entire Agreement 9.5. Several Obligations; Benefits of this Agreement 9.6. Expenses; Indemnification 9.7. Numbers of Documents 9.8. Accounting 9.9. Severability of Provisions 9.10 Nonliability of Lenders 9.11. CHOICE OF LAW 9.12. CONSENT TO JURISDICTION 9.13 WAIVER OF JURY TRIAL 9.14. Disclosure 9.15. Counterparts ARTICLE X THE AGENT 10.1. Appointment; Nature of Relationship 10.2. Powers 10.3. General Immunity 10.4. No Responsibility for Loans, Recitals, etc. 10.5. Action on Instructions of Lenders 10.6. Employment of Agents and Counsel 10.7. Reliance on Documents; Counsel 10.8. Agent's Reimbursement and Indemnification 10.9. Notice of Default 10.10. Rights as a Lender 10.11. Lender Credit Decision 10.12. Successor Agent 10.13. Agent's Fees 10.14. Delegation to Affiliates 10.15. Execution of Collateral Documents 10.16. Collateral Releases ARTICLE XI SETOFF; RATABLE PAYMENTS 11.1. Setoff 11.2.

REPRESENTATIONS AND WARRANTIES 5. 1Section 2.1. Corporate ExistenceRepresentations and Warranties of the City 5 Section 2.2. Representations and Warranties of the Developer 5 ARTICLE III UNDERTAKINGS BY DEVELOPER AND CITY 7 Section 3.1. Total Development Costs 7 Section 3.2. Reimbursement; Conduct of Interfund Loan 7 Section 3.3. Agreement to Pay Tax Abatement Shortfall. 7 Section 3.4. Business 5.2Subsidy Act 9 Section 3.5. Authorization Developer to Pay City Fees and Validity 5.3Expenses 10 Section 3.6. Compliance with Laws Environmental Requirements 10 Section 3.7. Construction Plans 11 Section 3.8. Commencement and Contracts Completion of Construction 11 Section 3.9. Certificate of Completion 12 Section 3.10. Additional Responsibilities of the Developer 12 Section 3.11. Encumbrance of the Development Property 13 Section 3.12. Real Property Taxes 13 ARTICLE IV EVENTS OF DEFAULT 15 Section 4.1. Events of Default Defined 15 Section 4.2. Remedies on Default 15 Section 4.3. No Remedy Exclusive 16 Section 4.4. No Implied Waiver 16 Section 4.5. Indemnification of the City 16 Section 4.6. Reimbursement of Attorneys’ Fees 17 Section 4.7. Developer Remedies on Default 17 ARTICLE V ADDITIONAL PROVISIONS 18 Section 5.1. Restrictions on Use 18 Section 5.2. Reports 18 Section 5.3. Limitations on Transfer and Assignment 18 Section 5.4. Governmental Consents Conflicts of Interest 19 Section 5.5. Financial Statements Titles of Articles and Sections 19 Section 5.6. Material Adverse Change Notices and Demands 19 Section 5.7. Taxes No Additional Waiver Implied by One Waiver 20 Section 5.8. Litigation and Contingent Obligations Counterparts 20 Section 5.9. Subsidiaries Law Governing 20 Section 5.10. ERISA Term; Termination 20 Section 5.11. Defaults Provisions Surviving Rescission, Expiration or Termination 20 Section 5.12. Federal Reserve Regulations Superseding Effect 20 Section 5.13. Investment Company Act Relationship of Parties 20 Section 5.14. Certain Fees Venue 21 Section 5.15. Ownership Merger 21 EXHIBIT A DESCRIPTION OF DEVELOPMENT PROPERTY .......................................... A-1 EXHIBIT B SOURCES AND USES ........................................................................................B-1 EXHIBIT C CERTIFICATE OF COMPLETION OF PROJECT ............................................C-1 EXHIBIT D PREPAYMENT SCHEDULE ............................................................................. D-1 TAX ABATEMENT AGREEMENT THIS AGREEMENT, made as of Properties 5.16. Collateral 5.17. Material Agreements 5.18. Insurance 5.19. Disclosure ARTICLE VI COVENANTS 6.1. Financial Reporting 6.2. Use the day of Proceeds 6.3. Notice April, 2017, the City of Default 6.4. Conduct Chaska, Minnesota (the “City”), a municipal corporation under the Constitution and laws of Business 6.5. Taxes 6.6. Insurance 6.7. Compliance with Laws 6.8. Maintenance the State of Properties 6.9. Inspection 6.10. Security Agreement 6.11. Merger 6.12. Sale of Assets 6.13. Investments Minnesota, and Purchases 6.14. Contingent Obligations 6.15. Liens 6.16. Affiliates 6.17. Change in Corporate Structure; Fiscal Year 6.18. Inconsistent Agreements 6.19. Financial Covenants 6.19.1 Minimum Tangible Net Worth 6.19.2. Net Capital Ratio 6.20. ERISA Compliance 6.21. Further Assurances ARTICLE VII DEFAULTS 7.1. Representation or Warranty 7.2. Non-Payment 7.3. Specific Defaults 7.4. Other Defaults 7.5. Cross-Default 7.6. Insolvency; Voluntary Proceedings 7.7. Involuntary Proceedings 7.8. Condemnation 7.9. Judgments 7.10. Security Agreement 7.11. SIPC 7.12. Conduct of Business 7.13. ERISA 7.14. Change in Control 7.15. Official Lien ARTICLE VIII ACCELERATIONMSP/Chaska Medical, WAIVERSLLC, AMENDMENTS AND REMEDIES 8.1. Acceleration 8.2. Amendments 8.3. Preservation of Rights 8.4. Remedies ARTICLE IX GENERAL PROVISIONS 9.1. Survival of Representations 9.2. Governmental Regulation 9.3. Headings 9.4. Entire Agreement 9.5. Several Obligations; Benefits of this Agreement 9.6. Expenses; Indemnification 9.7. Numbers of Documents 9.8. Accounting 9.9. Severability of Provisions 9.10 Nonliability of Lenders 9.11. CHOICE OF LAW 9.12. CONSENT TO JURISDICTION 9.13 WAIVER OF JURY TRIAL 9.14. Disclosure 9.15. Counterparts ARTICLE X THE AGENT 10.1. Appointment; Nature of Relationship 10.2. Powers 10.3. General Immunity 10.4. No Responsibility for Loans, Recitals, etc. 10.5. Action on Instructions of Lenders 10.6. Employment of Agents and Counsel 10.7. Reliance on Documents; Counsel 10.8. Agent's Reimbursement and Indemnification 10.9. Notice of Default 10.10. Rights as a Lender 10.11. Lender Credit Decision 10.12. Successor Agent 10.13. Agent's Fees 10.14. Delegation to Affiliates 10.15. Execution of Collateral Documents 10.16. Collateral Releases ARTICLE XI SETOFF; RATABLE PAYMENTS 11.1. Setoff 11.2.Minnesota limited liability company (the “Developer”),

REPRESENTATIONS AND WARRANTIES 5. 1Section 5.1. Corporate Existence; Conduct of Business Mutual Representations and Warranties 5 Section 5.2. Authorization The Originator’s Additional Representations and Validity Warranties 6 Section 5.3. Compliance with Laws Reaffirmation of Representations and Contracts Warranties by the Originator; Notice of Breach 10 Section 5.4. Governmental Consents 5.5. Financial Statements 5.6. Material Adverse Change 5.7. Taxes 5.8. Litigation and Contingent Obligations 5.9. Subsidiaries 5.10. ERISA 5.11. Defaults 5.12. Federal Reserve Regulations 5.13. Investment Company Act 5.14. Certain Fees 5.15. Ownership of Properties 5.16. Collateral 5.17. Material Agreements 5.18. Insurance 5.19. Disclosure Repurchases 10 ARTICLE VI COVENANTS 11 Section 6.1. Financial Reporting Affirmative Covenants of the SPV 11 Section 6.2. Use Affirmative Covenants of Proceeds the Originator 11 Section 6.3. Notice Negative Covenants of Default 6.4. Conduct of Business 6.5. Taxes 6.6. Insurance 6.7. Compliance with Laws 6.8. Maintenance of Properties 6.9. Inspection 6.10. Security Agreement 6.11. Merger 6.12. Sale of Assets 6.13. Investments and Purchases 6.14. Contingent Obligations 6.15. Liens 6.16. Affiliates 6.17. Change in Corporate Structure; Fiscal Year 6.18. Inconsistent Agreements 6.19. Financial Covenants 6.19.1 Minimum Tangible Net Worth 6.19.2. Net Capital Ratio 6.20. ERISA Compliance 6.21. Further Assurances the Originator 14 ARTICLE VII DEFAULTS TERM AND TERMINATION 15 Section 7.1. Representation or Warranty Term 15 Section 7.2. Non-Payment 7.3. Specific Defaults 7.4. Other Defaults 7.5. Cross-Default 7.6. Insolvency; Voluntary Proceedings 7.7. Involuntary Proceedings 7.8. Condemnation 7.9. Judgments 7.10. Security Agreement 7.11. SIPC 7.12. Conduct Effect of Business 7.13. ERISA 7.14. Change in Control 7.15. Official Lien Purchase Termination Date 15 TABLE OF CONTENTS (continued) Page ARTICLE VIII ACCELERATION, WAIVERS, AMENDMENTS AND REMEDIES INDEMNIFICATION 16 Section 8.1. Acceleration 8.2. Amendments 8.3. Preservation of Rights 8.4. Remedies Indemnities by the Originator 16 ARTICLE IX GENERAL MISCELLANEOUS PROVISIONS 18 Section 9.1. Survival of Representations Waivers; Amendments 18 Section 9.2. Governmental Regulation Notices 18 Section 9.3. Headings Governing Law 18 Section 9.4. Entire Agreement Integration 18 Section 9.5. Several Obligations; Benefits of this Agreement 9.6. Expenses; Indemnification 9.7. Numbers of Documents 9.8. Accounting 9.9. Severability of Provisions 9.10 Nonliability of Lenders 9.1118 Section 9.6. CHOICE OF LAW 9.12Counterparts; Facsimile Delivery 18 Section 9.7. CONSENT TO JURISDICTION 9.13 WAIVER OF JURY TRIAL 9.14Binding Effect; Assignment 18 Section 9.8. Disclosure 9.15. Counterparts ARTICLE X THE AGENT 10.1. Appointment; Nature of Relationship 10.2. Powers 10.3. General Immunity 10.4Costs, Expenses and Taxes 18 Section 9.9. No Responsibility Proceedings; Limited Recourse 19 Section 9.10. Further Assurances 19 Exhibit A Assignment Agreement Exhibit B Form of Supplement for LoansSubstitute Receivables Schedule I Originator Information Schedule II Lockbox Banks and Lockbox Account Information Schedule 5.2 Perfection Representations, RecitalsWarranties and Covenants SALE AGREEMENT This SALE AGREEMENT, etcdated as of June 13, 2011 (as amended, supplemented or otherwise modified and in effect from time to time, this “Agreement”), by and between COMMERCIAL CREDIT GROUP INC., a Delaware corporation (the “Originator”) and CCG RECEIVABLES V, LLC, a Delaware limited liability company (the “SPV”). 10.5. Action on Instructions of Lenders 10.6. Employment of Agents and Counsel 10.7. Reliance on Documents; Counsel 10.8. Agent's Reimbursement and Indemnification 10.9. Notice of Default 10.10. Rights The parties hereto agree as a Lender 10.11. Lender Credit Decision 10.12. Successor Agent 10.13. Agent's Fees 10.14. Delegation to Affiliates 10.15. Execution of Collateral Documents 10.16. Collateral Releases ARTICLE XI SETOFF; RATABLE PAYMENTS 11.1. Setoff 11.2.follows:

REPRESENTATIONS AND WARRANTIES 5. 1Section 5.1. Corporate Existence; Conduct of Business Mutual Representations and Warranties 5 Section 5.2. Authorization The Originator’s Additional Representations and Validity Warranties 6 Section 5.3. Compliance with Laws Reaffirmation of Representations and Contracts Warranties by the Originator; Notice of Breach 10 Section 5.4. Governmental Consents 5.5. Financial Statements 5.6. Material Adverse Change 5.7. Taxes 5.8. Litigation and Contingent Obligations 5.9. Subsidiaries 5.10. ERISA 5.11. Defaults 5.12. Federal Reserve Regulations 5.13. Investment Company Act 5.14. Certain Fees 5.15. Ownership of Properties 5.16. Collateral 5.17. Material Agreements 5.18. Insurance 5.19. Disclosure Repurchases 10 ARTICLE VI COVENANTS 10 Section 6.1. Financial Reporting Affirmative Covenants of the SPV 10 Section 6.2. Use Affirmative Covenants of Proceeds the Originator 11 Section 6.3. Notice Negative Covenants of Default 6.4. Conduct of Business 6.5. Taxes 6.6. Insurance 6.7. Compliance with Laws 6.8. Maintenance of Properties 6.9. Inspection 6.10. Security Agreement 6.11. Merger 6.12. Sale of Assets 6.13. Investments and Purchases 6.14. Contingent Obligations 6.15. Liens 6.16. Affiliates 6.17. Change in Corporate Structure; Fiscal Year 6.18. Inconsistent Agreements 6.19. Financial Covenants 6.19.1 Minimum Tangible Net Worth 6.19.2. Net Capital Ratio 6.20. ERISA Compliance 6.21. Further Assurances the Originator 13 ARTICLE VII DEFAULTS TERM AND TERMINATION 14 Section 7.1. Representation or Warranty Term 14 Section 7.2. Non-Payment 7.3. Specific Defaults 7.4. Other Defaults 7.5. Cross-Default 7.6. Insolvency; Voluntary Proceedings 7.7. Involuntary Proceedings 7.8. Condemnation 7.9. Judgments 7.10. Security Agreement 7.11. SIPC 7.12. Conduct Effect of Business 7.13. ERISA 7.14. Change in Control 7.15. Official Lien Purchase Termination Date 15 ARTICLE VIII ACCELERATION, WAIVERS, AMENDMENTS AND REMEDIES INDEMNIFICATION 15 Section 8.1. Acceleration 8.2. Amendments 8.3. Preservation of Rights 8.4. Remedies Indemnities by the Originator 15 TABLE OF CONTENTS (continued) Page ARTICLE IX GENERAL MISCELLANEOUS PROVISIONS 17 Section 9.1. Survival of Representations Waivers; Amendments 17 Section 9.2. Governmental Regulation Notices 17 Section 9.3. Headings Governing Law 18 Section 9.4. Entire Agreement Integration 18 Section 9.5. Several Obligations; Benefits of this Agreement 9.6. Expenses; Indemnification 9.7. Numbers of Documents 9.8. Accounting 9.9. Severability of Provisions 9.10 Nonliability of Lenders 9.1118 Section 9.6. CHOICE OF LAW 9.12Counterparts; Facsimile Delivery 18 Section 9.7. CONSENT TO JURISDICTION 9.13 WAIVER OF JURY TRIAL 9.14Binding Effect; Assignment 18 Section 9.8. Disclosure 9.15. Counterparts ARTICLE X THE AGENT 10.1. Appointment; Nature of Relationship 10.2. Powers 10.3. General Immunity 10.4Costs, Expenses and Taxes 18 Section 9.9. No Responsibility Proceedings; Limited Recourse 18 Section 9.10. Further Assurances 19 Exhibit A Assignment Agreement Exhibit B Form of Supplement for LoansSubstitute Receivables Schedule I Originator Information Schedule II Lockbox Banks and Lockbox Account Information Schedule 5.2 Perfection Representations, RecitalsWarranties and Covenants SALE AGREEMENT This SALE AGREEMENT, etcdated as of March 31, 2010 (as amended, supplemented or otherwise modified and in effect from time to time, this “Agreement”), by and between COMMERCIAL CREDIT GROUP INC., a Delaware corporation (the “Originator”) and CCG RECEIVABLES III, LLC, a Delaware limited liability company (the “SPV”). 10.5. Action on Instructions of Lenders 10.6. Employment of Agents and Counsel 10.7. Reliance on Documents; Counsel 10.8. Agent's Reimbursement and Indemnification 10.9. Notice of Default 10.10. Rights The parties hereto agree as a Lender 10.11. Lender Credit Decision 10.12. Successor Agent 10.13. Agent's Fees 10.14. Delegation to Affiliates 10.15. Execution of Collateral Documents 10.16. Collateral Releases ARTICLE XI SETOFF; RATABLE PAYMENTS 11.1. Setoff 11.2.follows: